Simulect Related Clinical Trials
Prospective, Randomized Trial of Basiliximab (Simulect) in the Prophylaxis of High-Risk Keratoplasty Patients [Completed]
Safety and Efficacy of Basiliximab in Calcineurin Inhibitor Intolerant Long-Term Kidney Transplant Recipients Treated With Mycophenolic Acid and Steroids [Active, not recruiting]
Study Comparing Simulect Plus Standard Immunosuppression to Standard Immunosuppression Alone for the Prevention of Acute Rejection and Bronchiolitis Obliterans in Lung Transplant [Active, not recruiting]
The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis [Not yet recruiting]
A Study to Investigate the Efficacy and Safety of a Therapy Avoiding Intraoperative Steroids in Combination With Basiliximab, Ciclosporin/Ciclosporin Microemulsion, and Steroids in Pediatric de Novo Liver Transplant Recipients [Recruiting]
Efficacy and Safety of Basiliximab in Hepatitis C Virus Positive Patients Undergoing Liver Transplantation [Active, not recruiting]
Basiliximab in Moderate to Severe Ulcerative Colitis [Recruiting]
Mesenchymal Stem Cells Under Basiliximab/Low Dose RATG to Induce Renal Transplant Tolerance [Recruiting]
An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in “de Novo” Liver Transplantation. [Active, not recruiting]
Study of Safety and Efficacy of a Basiliximab, Mycophenolate Mofetil, Cyclosporine Microemulsion and Prednisone Combination Treatment Regimen in Pediatric Renal Allograft Recipients [Active, not recruiting]
Phase IV Study to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal Transplantation [Recruiting]
Efficacy and Safety of AEB071 Versus Tacrolimus in Combination With Mycophenolate Acid Sodium, Basiliximab and Steroids in Preventing Acute Rejection After Kidney Transplantation [Completed]
Basiliximab for the Treatment of Acute Graft-Versus-Host Disease After Allogeneic Stem Cell Transplantation [Recruiting]
Concentration Controlled Everolimus With Reduced Dose Neoral Versus Mycophenolate Mofetil With Standard Dose Neoral in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids [Recruiting]
Study to Evaluate the Combination of Enteric-Coated Mycophenolate Sodium (EC-MPS), Basiliximab, and C2-Monitored Cyclosporine in De Novo Renal Transplant Recipients at Potential High Risk of Delayed Graft Function (DGF) [Completed]
EXTEND Protocol for Transplanted Patient to Evaluate Kidney Function [Not yet recruiting]
Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients [Active, not recruiting]
An Open-Label, Prospective, Randomized, Multi-Center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients. [Completed]
Study of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced-Dose Cyclosporine Microemulsion (CsA-ME) Compared to EC-MPS Plus Standard Dose CsA-ME in Eldery de Novo Renal Transplant Recipients Treated With Basiliximab and Short-Term Steroids [Active, not recruiting]
Preservation of Renal Function in Liver Transplant Recipients With Certican Therapy [Recruiting]
A Study to Assess the Safety and Efficacy of Alefacept in Kidney Transplant Recipients [Recruiting]
In-Vivo Activated T-Cell Depletion to Prevent GVHD [Recruiting]
Everolimus in a Cyclosporine Microemulsion-Free Regimen Compared to Standard Therapy in de Novo Kidney Transplant Patients [Active, not recruiting]
Everolimus in a Cyclosporine Microemulsion-Free Regimen Compared to a Low-Dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients [Active, not recruiting]
A Study in Kidney Transplant Subjects to Investigate the Optimal Suppression of Immunity to Help Prevent Kidney Rejection [Recruiting]
A Study to Evaluate Efalizumab Compared With Cyclosporine As an Immunosuppressant Regimen in De Novo Renal Transplantation [Not yet recruiting]
MYPROMS-ES02: Safety and Efficacy of Basiliximab, Cyclosporine Microemulsion and Enteric-Coated Mycophenolate Sodium (EC-MPS) Versus EC-MPS and Steroid Therapy in Kidney Transplant Recipients Who Are Hepatitis C Positive [Terminated]
CNI-Free de Novo Protocol in Patients Undergoing Liver Transplantation With Renal Impairment [Active, not recruiting]
Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in De Novo Renal Transplant Patients [Completed]
Safety and Efficacy of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Valsartan in Patients With Kidney Transplants (MYTHOS [Active, not recruiting]
Study Comparing the Safety and Efficacy of BMS-224818 to Cyclosporine, in Patients Receiving a Kidney Transplant, When Used in Combination With CellCept, Simulect, and Corticosteroids. [Completed]
Steroid Withdrawal in Pediatric Kidney Transplant Recipients [Active, not recruiting]
Freedom Study: Myfortic in Kidney Transplant Patients [Active, not recruiting]
LEA29Y (Belatacept) Emory Edmonton Protocol [Not yet recruiting]
Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes [Recruiting]
Belatacept in Liver Transplant Recipients [Recruiting]
MMF vs. AZA for Kidney Transplantation [Recruiting]
Study Comparing Sirolimus With Cyclosporine in a Calcineurin Inhibitor (CNI)-Free Regimen in Kidney Transplant Recipients [Terminated]
Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Kidney Transplant Recipients [Active, not recruiting]
Study Evaluating Sirolimus in Kidney Transplant Recipients. [Completed]
This is a 2-Year Follow-up Study to Evaluate the Long-Term Effects in Patients Who Completed the Study CRAD001A2307. [Completed]
Efficacy, Safety and Tolerability of AEB071 Versus Cyclosporine in the Novo Renal Transplant Recipients [Recruiting]
Induction Related BK Viremia in Renal Transplant Patients [Recruiting]
Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant Patients [Completed]
Concentration Controlled Versus Fixed Dose of MMF in Kidney Transplant Recipients [Active, not recruiting]
Comparison of Alemtuzumab/Tacrolimus Versus Interleukin-2 Receptor (IL-2R) Monoclonal Antibody (MoAb)/Tacrolimus/Mycophenolate in Kidney Transplantation [Active, not recruiting]
TACrolimus in Renal Transplantation: Individualization by Pharmacogenetic [Recruiting]
Clinical Islet Transplantation Using the Edmonton Protocol [Not yet recruiting]
|
